{"id":320,"date":"2019-04-02T10:24:01","date_gmt":"2019-04-02T09:24:01","guid":{"rendered":"http:\/\/fpc-huji.org\/?page_id=320"},"modified":"2019-04-02T11:30:25","modified_gmt":"2019-04-02T10:30:25","slug":"partners","status":"publish","type":"page","link":"https:\/\/fpc-huji.org\/?page_id=320","title":{"rendered":"Partners"},"content":{"rendered":"<div class=\"fhg-grid-item fhg-grid-3-2-1 fhg-content heading\">\n<h2>Successful cooperation<\/h2>\n<\/div>\n<div class=\"row\">\n<div class=\"fhg-grid-item fhg-grid-3-2-1 fhg-inline-image\">\n<div class=\"fhg-content fhg-richtext\">\n<p>The Institute for Drug Research at Hebrew University and Fraunhofer IGB have been working together in various projects. The main topics were on the one hand drug screening by combining <i>in-silico<\/i> and <i>in-vitro<\/i> methods for immunomodulating substances and on the other hand the development of new nanotransporters for RNA-based drugs against HSV1.<\/p>\n<hr \/>\n<\/div>\n<\/div>\n<\/div>\n<p>Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-321\" src=\"http:\/\/fpc-huji.org\/wp-content\/uploads\/2019\/04\/IGB_rgb-300x82.png\" alt=\"\" width=\"300\" height=\"82\" srcset=\"https:\/\/fpc-huji.org\/wp-content\/uploads\/2019\/04\/IGB_rgb-300x82.png 300w, https:\/\/fpc-huji.org\/wp-content\/uploads\/2019\/04\/IGB_rgb-768x210.png 768w, https:\/\/fpc-huji.org\/wp-content\/uploads\/2019\/04\/IGB_rgb.png 1004w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n<hr \/>\n<p>Institute for Drug Research at Hebrew University of Israel, Jerusalem<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-322\" src=\"http:\/\/fpc-huji.org\/wp-content\/uploads\/2019\/04\/huji_final_logos-300x102.png\" alt=\"\" width=\"300\" height=\"102\" srcset=\"https:\/\/fpc-huji.org\/wp-content\/uploads\/2019\/04\/huji_final_logos-300x102.png 300w, https:\/\/fpc-huji.org\/wp-content\/uploads\/2019\/04\/huji_final_logos-768x262.png 768w, https:\/\/fpc-huji.org\/wp-content\/uploads\/2019\/04\/huji_final_logos-1024x349.png 1024w, https:\/\/fpc-huji.org\/wp-content\/uploads\/2019\/04\/huji_final_logos.png 1738w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Successful cooperation The Institute for Drug Research at Hebrew University and Fraunhofer IGB have been working together in various projects. The main topics were on the one hand drug screening by combining in-silico and in-vitro methods for immunomodulating substances and on the other hand the development of new nanotransporters for RNA-based drugs against HSV1. Fraunhofer [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/fpc-huji.org\/index.php?rest_route=\/wp\/v2\/pages\/320"}],"collection":[{"href":"https:\/\/fpc-huji.org\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/fpc-huji.org\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/fpc-huji.org\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/fpc-huji.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=320"}],"version-history":[{"count":3,"href":"https:\/\/fpc-huji.org\/index.php?rest_route=\/wp\/v2\/pages\/320\/revisions"}],"predecessor-version":[{"id":337,"href":"https:\/\/fpc-huji.org\/index.php?rest_route=\/wp\/v2\/pages\/320\/revisions\/337"}],"wp:attachment":[{"href":"https:\/\/fpc-huji.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}